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Abstract
Background: Recent advances in genomics and proteomics have allowed us to study the nuances of the Warburg
effect – a long-standing puzzle in cancer energy metabolism – at an unprecedented level of detail. While modern
next-generation sequencing technologies are extremely powerful, the lack of appropriate data analysis tools makes
this study difficult. To meet this challenge, we developed a novel application for comparative analysis of gene
expression and visualization of RNA-Seq data.
Results: We analyzed two biological samples (normal human brain tissue and human cancer cell lines) with high-
energy, metabolic requirements. We calculated digital topology and the copy number of every expressed
transcript. We observed subtle but remarkable qualitative and quantitative differences between the citric acid (TCA)
cycle and glycolysis pathways. We found that in the first three steps of the TCA cycle, digital expression of
aconitase 2 (ACO2) in the brain exceeded both citrate synthase (CS) and isocitrate dehydrogenase 2 (IDH2), while in
cancer cells this trend was quite the opposite. In the glycolysis pathway, all genes showed higher expression levels
in cancer cell lines; and most notably, digital gene expression of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and enolase (ENO) were considerably increased when compared to the brain sample.
Conclusions: The variations we observed should affect the rates and quantities of ATP production. We expect that
the developed tool will provide insights into the subtleties related to the causality between the Warburg effect
and neoplastic transformation. Even though we focused on well-known and extensively studied metabolic
pathways, the data analysis and visualization pipeline that we developed is particularly valuable as it is global and
pathway-independent.
Background
Profound differences between the metabolic pathways of
normal and cancer cells have been known since 1926
when Otto Warburg attributed tumors to dysfunctional
mitochondria [1]. Normal eukaryotic cells generate
energy in the form of adenosine triphosphate (ATP)
through a combination of glycolysis and the TCA path-
way. The TCA pathway consists of enzymes encoded by
8 genes and the full cycle generates 36 molecules of
ATP. On the other hand, glycolysis is a linear pathway
that comprises enzymes encoded by 10 genes and pro-
duces only 2 molecules of ATP [2,3]. Under normal
conditions glycolysis preferentially occurs in hypoxic cir-
cumstances yielding lactic acid [4]. In many types of
cancer, glycolysis is the preferable method for meeting
energy demands in cells undergoing uncontrolled
growth even in the presence of oxygen [5]. This drastic
metabolic shift is essentially the well-known Warburg
effect [1]. While enzymes and substrates of the TCA
cycle and glycolysis have been extensively studied, the
causality between the Warburg effect and cancer
remains unknown [6].
Improvements in ‘-omics’-based technologies, in parti-
cular genomics and proteomics, have allowed us to
examine at a new level the molecular details of the
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Warburg effect. For example, it has been found that
tumor glycolysis enhances activation of oncogene and
loss of tumor suppressor gene activity by stabilization of
the hypoxia-inducible factor (HIF), a transcription factor
that regulates 9 out of 10 enzymes involved in glycolysis
[5]. However, molecular differences between the TCA
cycle and glycolysis and the impact of the expression of
genes on rates and quantities of ATP production is cur-
rently unknown.
Metabolic pathways are regulated at several levels,
including mRNA transcription, translation, and protein
interaction [2]. We used next- (or second-) generation
sequencing technology with RNA-Seq to study the TCA
cycle and glycolysis at the transcriptional level of genes
encoding their enzymes. This genomics approach is
based on the analysis of digital gene expression and is
capable of generating millions of short sequences [7,8].
While the second-generation sequencing technology can
provide unprecedented levels of detail, one of its main
challenges is the unavailability of intuitive, publicly avail-
able universal tools that can retrieve, process and visua-
lize large amounts of generated data in a single package.
Hundreds of computational programs for analysis of
massive quantities of short reads are already available in
the public domain [9]. These programs were designed
either for read alignment [10,11], analysis of alternative
splicing and gene expression [12,13] or visualization
[14-16]. Our contribution with the presented work is
creation of a package that leverages publicly available
programs for next generation sequencing data analysis.
This package aligns “reads” (or cDNA sequences), quan-
tifies gene expression (in terms of RNA level) and visua-
lizes results in a simple flow of linear data analysis.
Interpretation of second-generation sequencing data
requires expertise in quality control, alignment of reads,
quantitation of expression and visualization of massive
volumes of data. These steps are commonly embedded
in custom-made data analysis pipelines that consist of
several steps and typically use some of the aforemen-
tioned programs. The data analysis process is performed
in a specific order in which output of one operation is
used as an input for the next one. Such an approach is
highly non-trivial and may still present a challenge for
sequencing facilities significantly smaller in size and
resources than the National Human Genome Research
Institute-funded large genomic centers [17]. To meet
this challenge, we have developed Transcriptome Analy-
sis with Circos (TrAC), a novel tool for comparative
analysis and visualization of short reads based on Circos
[16]. TrAC is a highly customizable RNA-Seq tool
applicable for global transcriptome analysis with the
additional feature that the visualization step deviates
from the “one-gene-at-a-time” paradigm commonly
practiced by the popular genome browsers [14,15]. With
TrAC users can visualize whole pathways, cycles within
pathways or linear segments of genes in any given con-
figuration. We applied this tool to study energy metabo-
lism in tissues with high-energy requirements such as
normal brain and cancer cell lines.
Results and discussion
We analyzed genes that encode enzymatic components
involved in essential steps within metabolic pathways.
There were 8 main enzymes (and their encoding genes)
involved in the TCA cycle, and 10 main enzymes and
genes in glycolysis (Table 1). As illustrated in standard
biochemistry books, all the enzymes and substrates that
participate in the TCA cycle and glycolysis have been
known for a long time. However, we could find no defi-
nitive information on gene expression, at transcript
level, for any of the genes involved in each of the two
pathways. For example, for HK1, which encodes hexoki-
nase 1, the entry step in glycolysis, the National Center
for Biotechnology Information Reference Sequence
(RefSeq) recognizes 5 alternatively spliced variants
(NM_000188.2, NM_033497.2, NM_033498.2,
NM_033500.2, NM_033496.2). For the purpose of visua-
lization and to avoid overcrowding in the figures, we
choose to present the longest transcripts only; i.e.,
NM_033500.2 for HK1. The mRNA sequence of each
presented gene was selected in a similar manner from
RefSeq database [18,19].
RNA-Seq data processing
Reads generated on the next-generation sequencing plat-
form from brain and cancer samples were aligned against
elements from the human RefSeq database. In our read
mapping with Bowtie [10], we imposed default para-
meters with two mismatches within the first 28 nucleo-
tides (nt) of each read relative to the reference. From
aligned short sequences, we calculated the digital expres-
sion signal by determining the number of mapped reads
at each base on the reference. Visualization of the digital
signal in the form of a histogram allowed us to investi-
gate transcript topology. In particular, we were able to
study the differences in sequencing coverage within the
whole transcripts, genes, and exons (Figure 1A).
In order to provide biological meaning for the reads
mapped on the reference and to report the digital
expression signal as a scalar value, for each gene we
considered both the number of mapped reads and the
mapped length in base pairs. To quantify this expres-
sion, the ratio between mapped reads and transcribed
length was appropriately rescaled with the total number
of mapped reads and the total mapped transcriptome
size, as previously described [20]. An example of the
raw read count is shown in Figure 1A, while estimates
of expression of each exon are shown in Figure 1B.
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Table 1 Core genes of the TCA cycle and glycolysis




1431 NM_004077 TCA cycle 11.2 7.4
ACO2
(Aconitase 2)
50 NM_001098 TCA cycle 7.8 20.7
IDH2
(isocitrate dehydrogenase 2)
3418 NM_002168 TCA cycle 13.1 6.2
OGDH
(oxoglutarate dehydrogenase)
4967 NM_001165036 TCA cycle 2.8 3.3
SUCLA2
(succinate-CoA ligase)
8803 NM_003850 TCA cycle 1.1 2.1
SDHA
(succinate dehydrogenase complex, sub. A)
6389 NM_004168 TCA cycle 20.5 15.4
FH
(fumarate hydratase)
2271 NM_000143 TCA cycle 6.5 2.8
MDH1
(malate dehydrogenase 1)
4190 NM_005917 TCA cycle 10.4 26.2
HK1
(hexokinase 1)
3098 NM_033500 Glycolysis 2.3 3.0
GPI
(glucose-6-phosphate isomerase)
2821 NM_000175 Glycolysis 11.9 10.3
PFKL
(phosphofructokinase, liver)
5211 NM_002626 Glycolysis 21.7 10.3
ALDOA
(aldolase A, fructose-bisphosphate)
226 NM_000034 Glycolysis 49.9 25.0
TPI1
(triosephosphate isomerase 1)
7167 NM_001159287 Glycolysis 68.4 29.8
GAPDH
(glyceraldehyde-3-phosphate dehydrogenase)
2597 NM_002046 Glycolysis 886.6 287.3
PGK1
(phosphoglycerate kinase 1)
5230 NM_000291 Glycolysis 67.4 15.1
PGAM1
(phosphoglycerate mutase 1)
5223 NM_002629 Glycolysis 41.5 27.6
ENO1
(enolase 1)
2023 NM_001428 Glycolysis 264.2 51.3
PKM2
(pyruvate kinase)
5315 NM_002654 Glycolysis 37.7 21.3
Figure 1 RNA-Seq data representation RNA sequencing reads coverage of five exons of the aconitase ACO2 gene. Exons are blue bars; reads
are presented in green. A Digital transcript topology generated by accumulation of every read mapped within a specific region (exon, intron, or
transcript). B Absolute copy number provided a means to quantity transcribed products in the sample.
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Under the assumption of uniform read coverage, this
copy number of transcripts corresponds to the amount
of every expressed RNA present in the sample and is
directly proportional to the RPKM (Reads mapping to
the genome Per Kilobase of transcript per Million reads
sequenced) value [20].
The TCA cycle analysis
Gene expression values across samples were noticeably
different. In the brain tissue, the trend in the first
three steps of the TCA cycle, which involves the
citrate synthase gene CS, aconitase ACO2 and the iso-
citrate dehydrogenase IDH2 gene, was qualitatively and
quantitatively distinct relative to the trend observed in
cancer. In particular, the number of transcribed copies
of ACO2 was higher than the numbers of CS and
IDH2; however, in the cancer sample the situation was
quite the opposite with copy numbers of CS and IDH2
exceeding ACO2 expression. We also noticed that the
ratio of expression level of malate dehydrogenase
MDH to fumarate hydratase FH in the brain sample
was 8.6 while in the neoplastic sample it was 1.6 (Fig-
ure 2A). Previous work on yeast indicates that muta-
tions in isocitrate dehydrogenase affect DNA instability
[21]. For humans, a drastic change in CS expression,
which may be further stimulated by excess concentra-
tion of Zn2+ ions and leads to changes in the local
pH, has been observed in prostate carcinogenesis
[22,23].
Visualization of digital expression demonstrated that
sequence coverage by transcriptomic tool RNA-Seq is
non-uniform but exhibits a highly reproducible pattern
across different samples, as shown in Figure 2. The pat-
terns were especially obvious in the case of ACO2 and
MDH1 in the TCA cycle. In both samples, the ACO2 and
SDHA genes were well covered with reads along the
whole length of the transcripts. However, the MDH cov-
erage was biased towards the 5’ end and the middle of
the transcript, whereas very few reads mapped to the 3’
end (Figure 2A).
Glycolysis analysis
Every gene in the glycolysis pathway showed stronger
expression in neoplastic cells than in the brain. The abso-
lute transcript numbers of genes in both samples fol-
lowed a similar pattern within first five steps in the
pathway: the expression level gradually increased. How-
ever there were several steps in glycolysis that had very
high levels of expression in both types of cells. In particu-
lar the digital signal for GAPDH and ENO were consider-
ably higher in both samples when compared to other
genes in the pathway. Furthermore, in cancer cell lines
the copy numbers of GAPDH and ENO were 3 and 5
times higher than in brain tissue, respectively (Figure 2B).
Discussion
As expected, we showed profound differences in activ-
ities of genes involved in two major metabolic pathways:
Figure 2 Metabolic pathways Main genes (maroon) of the TCA cycle (A) and glycolysis (B). The brain sample is shown in grey; the cancer
sample is shown in pink. Copy number of each transcript is shown as a bar. The height of the bar corresponds to the quantity of the transcript
present in the sample. Digital transcript topology for each gene shown as ‘wiggles’.
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the TCA cycle and glycolysis. The analyzed samples,
brain and cancer cell lines, were of particular interest
because of their similar high-energy requirements. We
also showed remarkable differences in the baseline
expression level for genes involved in the TCA cycle
and glycolysis across different normal tissues (Figure 3).
Illumina, Inc (San Diego, California, U.S.) under the
BodyMap Project sequenced these tissues.
Our approach revealed both quantitative signals for
digital expression and topology of transcript coverage
for all analyzed genes. The next generation mRNA
sequencing provides an unbiased view of complete tran-
scriptomes. To begin to make sense of transcriptomes
represented by large and growing volumes of sequencing
data, we need to be able to focus on individual subsets
of genes. Topologically speaking, every pathway consists
of one of the two major building blocks: a closed loop
(such as the TCA cycle) and a linear cascade (such as
glycolysis). The tool that we present, Transcriptome
Analysis with Circos or TrAC, is our version of an
Figure 3 The TCA cycle across different tissues Gene expression values of the TCA cycle genes across six different tissues from the Human
BodyMap Project by Illumina.
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unbiased approach to data analysis because it allows end
users to pursue both hypothesis-driven and hypothesis-
generating research. In hypothesis- driven analyses, the
genes that participate in the major pathways are mainly
known. TrAC is also suitable for hypothesis-generating
research because an arbitrary list of genes that represent
substructures of transcriptional networks can be very
efficiently quantitated and visualized. This is a signifi-
cant advantage over popular genome viewers such as
Integrated Genomics Viewer, developed at the Broad
Institute, that is constrained to visualize a single gene or
a contiguous stretch of DNA on the same chromosome,
but by default cannot quantitate gene expression or be
used for differential expression. TrAC, therefore, repre-
sents a shift in NGS data analysis because it can do
both. Moreover it is very flexible about its input, as it
simply requires a list of fastq files and a list of genes of
interest for analysis.
To appreciate the discovery potential of TrAC, we
examined two major, extremely well-studied carbohy-
drate metabolic pathways for which we still have a very
limited understanding of the transcriptional control and
consequences of gene activity.
The differences that we observed in ENO expression
in cancer cell lines versus brain support the hypothesis
that ENO plays a role in pyruvate channeling towards
the TCA cycle in mitochondria [24]. On the other
hand, with the exception of breast, head and neck, and
bone marrow cancers, ENO tends to be overexpressed
in a majority of cancers [3]. With the mitochondrial
aconitase gene, ACO2, it is quite the opposite as it is
generally overexpressed in a small number of cancers
such as melanoma and lung cancers [3]. In the P3
prostate cancer cell line, inhibition of ACO2 did not
cause a major shift in ATP production, but inhibition
of both glycolysis and respiration were necessary to
decrease the ATP content [25]. From a bioinformatics
standpoint, the ACO2 transcript is of particular inter-
est because a microarray probe on the human Illumina
gene arrays cannot be mapped using stringent mapping
criteria (MAQC) since the probe has two mismatches
relative to the reference. On the other hand, two mis-
matches on a 75bp-long read in next generation
mRNA sequencing experiments are less of a problem
because large numbers of reads do not all have to be
of superb quality to provide confidence about gene
expression.
Biological interpretation of the results presented
would require experimental design beyond the scope of
this study. In the absence of a carefully designed experi-
ment to study changes in a global gene expression net-
work due to manipulation of the main genes in the
TCA cycle and glycolysis, we can attempt to understand
the gene activity associated with these two processes
through visualization with TrAC. While the objective of
the work presented was not to explain the long-standing
puzzle of the Warburg effect, the described package,
TrAC, represents a viable tool for guiding the analysis.
We expect that TrAC will simplify data analysis for
non-bioinformaticians (manuscript in preparation). As
discussed, TrAC can be scaled up to hundreds of genes
involved in metabolic pathways; and we propose it as a
bioinformatics tool for a simplified multi-gene rather
than single-gene approach in biological problems.
Conclusions
Next-generation sequencing technology was used to
study gene expression/activity differences in metabolic
pathways between normal and neoplastic cells. For this
study we developed and implemented TrAC – Tran-
scriptome Analysis with Circos, a novel computational
data analysis and visualization tool. With the TrAC
pipeline, we were able to process RNA-Seq data and
from large volumes of sequencing data extract mean-
ingful insights into a biological problem. Transcript
copy numbers of the main genes involved in carbohy-
drate metabolism in brain and cancer cells were esti-
mated and different gene expression patterns within
two samples were revealed. We expect that this analy-
tical tool will provide further insights into the subtle-
ties related to the causality of the Warburg effect and
neoplastic transformation. Our future research will
involve translational investigation of the influence of
described variations on the rates and qualities of ATP
production in normal and neoplastic cells. Although
we focused on the genes involved in the main steps of
the TCA cycle and glycolysis, the developed approach
is global and pathway-independent. TrAC is fully cus-
tomizable and allows end-users to study any gene




Analysis of energy metabolism was performed on high
quality RNA samples of normal brain and cancer cell
lines. The brain sample consisted of FirstChoice Human
Brain Reference RNA (HBRR by Ambion, cat
#AM6050), pooled from multiple donors and several
brain regions. The cancer sample was the Universal
Human Reference RNA (UHRR by Stratagene), com-
posed of RNA from 10 human cell lines [26]. These
samples were sequenced by Illumina using the Genome
Analyzer platform for the Sequencing Quality Control
project, in a follow up to a large FDA-led Microarray
Quality Control (MAQC Consortium) project [27]. In
particular, we used 46.8 million HBRR and 50.6 million
UHRR in 50 nt-long single-end reads.
Markovets and Herman BMC Bioinformatics 2011, 12(Suppl 10):S8
http://www.biomedcentral.com/1471-2105/12/S10/S8
Page 6 of 8
A pipeline for analysis and visualization of RNA-Seq data
The analysis of RNA-Seq data consisted of several steps:
pre-processing, alignment, post-processing, and visuali-
zation. The pre-processing step consists of preparing
reads for the alignment. The information content of
each unique read was calculated according to the Shan-
non entropy formula (manuscript in preparation). The
rationale for this filtering was our finding that the
aligner tends to spend most of the CPU time aligning
uninformative reads such as mononucleotide repeats
from polyA tails or dinucleotide simple repeats; so filter-
ing out such reads prior to the mapping significantly
improved run times. Second, reads were sorted in an
alphabetical order that facilitated the alignment process
by providing the aligner with efficient data structure.
After this initial step in the data analysis, the high infor-
mation content unique reads were aligned with Bowtie
[10], a freely available, memory- efficient and very fast
short-read alignment software package. We aligned
against the RefSeq [19] release downloaded in October
of 2010 with a query to the NCBI web site as previously
described [27]. We allowed up to two mismatches in the
alignment. Mapped reads were saved in sorted SAM for-
mat that was used for gene expression quantitation esti-
mates and post-processing visualization. We plotted the
pileup vectors of digital expression for each expressed
transcript to visualize transcript topology and read cov-
erage. The number of reads and the covered transcript
length were further used to estimate the number of
transcribed mRNA copies of genes involved in main
steps of cell metabolism. These results were finally
visualized using the free software package Circos [16].
Data analysis
In order to study topology of the transcripts, genes, or
exons for reads aligned on the RefSeq reference, we gen-
erated a pile-vector for each transcript. This vector con-
sisted of an integer count of mapped read coverage at
each nucleotide position in a reference. Visualization of
pile-vector allowed us to investigate the different fea-
tures of transcript regions that we were interested in.
For every gene the estimated copy number (digital
gene expression) was calculated by taking into account
the number of mapped reads and the length of the tran-
script, appropriately rescaled with the total number of









where NGene is a number of mappable reads aligned
on the gene’s exons; LGene is the sum of the gene’s exon
lengths; NTranscriptome is the total number of mappable
reads in the experiment; LTranscriptome is the length of
the transcriptome.
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